These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4125741)

  • 1. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
    Pacilio G; Puzziello T
    Bronches; 1971; 21(4):402. PubMed ID: 4340778
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Selawry OS
    Cancer Chemother Rep 3; 1973 Mar; 4(2):177-88. PubMed ID: 4277763
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
    Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester T; Shapiro CM; Billings A; Rubenstein L; Evans R; Colman M; Rao CY; Griem M; Golomb HM
    Cancer Treat Rep; 1978 Mar; 62(3):327-32. PubMed ID: 348305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy in advanced cancer of the lung].
    Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
    Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for lung cancer.
    Golbey RB
    Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
    Wright JC
    J Natl Med Assoc; 1985 Oct; 77(10):815-27. PubMed ID: 2414458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.